Phase III, randomized, double‑blind, multicenter clinical trial to evaluate the efficacy of sildenafil citrate in reducing adverse perinatal events during labour in small‑for‑gestational‑age fetuses
Labour can be a stressful time for any baby, but it can be especially hard on babies who are smaller than expected for their stage of pregnancy (known as small-for-gestational-age). These babies have a higher risk of distress during contractions, which sometimes leads to emergency caesarean sections or admissions to a neonatal intensive care unit. This Phase III clinical trial is testing a medicine called sildenafil citrate against a dummy pill (placebo). Sildenafil works by relaxing blood vessels and improving blood flow to the womb. Doctors want to see if giving this tablet to mothers during labour can improve oxygen flow to the baby, reduce birth complications, and lower the chances of the baby needing urgent medical care after delivery. Taking part involves receiving either the study tablet or a placebo while in labour, alongside standard maternity care.
At a glance
What is this study about?
During labour, the womb tightens to help push the baby out. Each contraction temporarily reduces blood flow through the placenta. Most babies cope well with this, but babies who are smaller than average may struggle to get enough oxygen. When this happens, doctors may need to step in quickly with an emergency caesarean or an assisted delivery using forceps or a ventouse suction cup. After birth, some of these babies also need extra support in a neonatal care unit.
This clinical trial is investigating whether a tablet called sildenafil citrate can protect these smaller babies. Sildenafil helps open up blood vessels, which may improve the flow of blood and oxygen through the placenta and umbilical cord during labour. Researchers hope that by supporting blood flow when the womb contracts, babies will stay healthier and experience less distress.
To find out if the treatment truly works, researchers are comparing sildenafil to a placebo, which looks identical but contains no active medicine. Neither you nor your care team will know which tablet you receive until the trial ends. By comparing outcomes, doctors hope to discover a safe, simple way to protect smaller babies during birth and give them the best possible start in life.
Key takeaways
- This trial is testing whether sildenafil can help smaller babies cope better with the stress of labour.
- Participants take either a sildenafil tablet or a dummy pill (placebo) while giving birth.
- The main goal is to reduce the need for emergency caesareans and special neonatal care.
- You and your baby will be closely monitored by doctors and midwives throughout.
- Taking part is completely voluntary and will not change your normal birth choices or pain relief.
Who may be eligible?
This study is designed for pregnant women who are at least 18 years old and are carrying a baby that has been identified as smaller than average for its gestational age. This usually means ultrasound scans during pregnancy have shown that the baby's growth is tracking lower than typical charts.
To be considered, you must be planning to give birth at one of the participating hospital maternity units. You will need to be in the early stages of labour or having your labour induced, and your healthcare team must consider it safe for you to take part.
Women who have certain existing medical conditions, severe heart issues, allergies to sildenafil, or specific pregnancy complications that require immediate delivery without delay will not be able to join. Your midwife or obstetrician will carefully review your notes to confirm if the trial is suitable for you and your baby.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am 18 years of age or older.
- I am currently pregnant and carrying a baby measuring smaller than average.
- I am planning to give birth at a participating hospital.
- I am in early labour or scheduled for labour induction.
- I am happy to take a study tablet (or placebo) and have standard monitoring during birth.
What does participation involve?
If you choose to take part, you will be given a tablet to take by mouth during labour. This will either be sildenafil citrate (50 mg) or an inactive dummy pill (placebo). A computer chooses which one you get at random, like flipping a coin.
Throughout your labour, you and your baby will be monitored closely. The maternity team will carry out standard checks, which may include ultrasound scans to look at blood flow in your womb and umbilical cord. After your baby is born, doctors will check their health, measure their birth weight, and note whether they need any extra care, such as time in a neonatal unit.
Your participation mainly takes place while you are in the hospital having your baby. The team will follow up on you and your baby's progress during your normal hospital stay, usually up to about seven days after birth or until you are both discharged home.
Potential risks and benefits
Locations (1)
- —UnverifiedSpain
Common questions
Will taking this medicine affect my pain relief choices?
No. Taking part will not stop you from having pain relief, such as gas and air, pethidine, or an epidural, as advised by your maternity team.
Can I choose whether I get the real medicine or the placebo?
No. A computer randomly decides who receives the active tablet and who receives the placebo so that the test results remain fair and unbiased.
Is sildenafil safe to take during labour?
Sildenafil has been studied in pregnancy, but this trial is designed to confirm whether it is both safe and effective during labour. You and your baby will be monitored closely throughout.
What happens if my baby shows signs of distress?
Your safety and your baby's safety always come first. If your baby shows signs of distress, doctors will act immediately and provide standard emergency care, regardless of the study.
Do I have to pay anything to take part?
No. All study-related medicines and tests are provided free of charge, and your standard NHS care remains unchanged.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.